Operating
D&A
McKesson D&A decreased by 1.6% to $62.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.6%, from $63.00M to $62.00M.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
Detailed definition
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Peer comparison
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
Metric ID:
cf_depreciation_and_amortizationHistorical Data
5 periods
| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|
| Value | $80.00M | $61.00M | $64.00M | $63.00M | $62.00M |
| QoQ Change | — | -23.8% | +4.9% | -1.6% | -1.6% |
| YoY Change | — | -23.8% | +4.9% | -1.6% | -1.6% |
Range$61.00M – $80.00M
CAGR-22.5%
Avg YoY Growth-5.5%
Median YoY Growth-1.6%
Current Streak2 quarters decline
Business Segments
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Oncology & Multispecialty | — | — | — | — | — | — | $71.00M | $63.00M |
| North American Pharmaceutical | — | — | — | — | — | — | $32.00M | $34.00M |
| Medical-Surgical Solutions | $16.00M | $23.00M | $22.00M | $23.00M | $22.00M | $22.00M | $23.00M | $26.00M |
| Prescription Technology Solutions | — | $21.00M | $22.00M | $22.00M | — | $21.00M | $20.00M | $21.00M |
| International | — | $30.00M | — | — | — | $14.00M | — | — |
| U.S. Pharmaceutical | — | $60.00M | — | — | — | $63.00M | — | — |
| Total | — | $63.00M | — | — | — | $62.00M | — | — |
International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
D&A at Other Companies
Frequently Asked Questions
- What is McKesson's d&a?
- McKesson (MCK) reported d&a of $62.00M in Q2 2025.
- How has McKesson's d&a changed year-over-year?
- McKesson's d&a decreased by 1.6% year-over-year, from $63.00M to $62.00M.
- What does d&a mean?
- The accounting process of spreading the cost of physical and intangible assets over time.